Your session is about to expire
← Back to Search
Prone Positioning for COVID-19
N/A
Waitlist Available
Led By Lucie Uncapher
Research Sponsored by Poudre Valley Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 6 days
Awards & highlights
Study Summary
This trial will help determine if early self-proning may prevent intubation and improve mortality in patients with COVID-19 pneumonia.
Eligible Conditions
- COVID-19
- Coronavirus
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 6 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 6 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Incidence of intubation
Secondary outcome measures
Length of Stay
Maximum oxygen requirement
Mortality
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Supine PositioningExperimental Treatment1 Intervention
Supine Positioning
Group II: Prone PositioningExperimental Treatment1 Intervention
Prone positioning
Find a Location
Who is running the clinical trial?
Poudre Valley Health SystemLead Sponsor
16 Previous Clinical Trials
683 Total Patients Enrolled
1 Trials studying COVID-19
120 Patients Enrolled for COVID-19
Lucie UncapherPrincipal InvestigatorUniversity of Colorado Health
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger